Aethlon Medical Inc (NAS:AEMD)
$ 0.4 -0.4501 (-52.95%) Market Cap: 1.05 Mil Enterprise Value: -4.73 Mil PE Ratio: 0 PB Ratio: 0.14 GF Score: 51/100

Q2 2023 Aethlon Medical Inc Earnings Call Transcript

Nov 14, 2022 / 09:30PM GMT
Release Date Price: $4.96 (+0.28%)
Operator

Good afternoon and welcome to the Aethlon Medical second-quarter fiscal 2022 earnings and corporate update conference call. (Operator Instructions) Please note this event is being recorded.

I'd now like to turn the conference over to Jim Frakes, CFO. Please go ahead.

Jim Frakes
Aethlon Medical, Inc. - CFO & SVP, Finance

Thank you, operator. And good afternoon, everyone. Welcome to Aethlon Medical's second-quarter earnings conference call. My name is Jim Frakes, and I'm Aethlon's Chief Financial Officer. At 4:15 PM Eastern Time today, Aethlon Medical released financial results for its second quarter ended September 30, 2022. If you have not seen or received Aethlon Medical's earnings release, please visit the investors page at www.aethlonmedical.com.

Following this introduction and the reading of our forward-looking statements, Aethlon's CEO, Dr. Chuck Fisher; our Chief Medical and Chief Scientific Officer, Dr. Steven LaRosa; and our Chief Business Officer, Guy

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot